BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/19/2025 6:20:03 AM | Browse: 19 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 107971
Country China
Category Oncology
Manuscript Type Basic Study
Article Title SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Xue-Jing Lin, Er-Jiang Tang, Bin Sun, Ai-Li Wang, Ying Chen, Lei Chen, Yi-Yang Xue, A-Jian Li and Chun-Ying Liu
Funding Agency and Grant Number
Funding Agency Grant Number
Shanghai Yangpu District Science and Technology Commission No. YPQ202303
Shanghai Municipal Health Commission Clinical Research Special Project No. 2022410122
Shanghai Medical Innovation Research Special Project No. 22Y11908600
Corresponding Author Chun-Ying Liu, Associate Professor, PhD, National Center for Liver Cancer, Naval Medical University, No. 366 Qianjv Road, Shanghai 201805, China. cyliu@sibcb.ac.cn
Key Words SAC3 domain containing 1; Metabolic reprogramming; Glycolysis; Adenosine triphosphate production; β-Catenin/c-Myc axis; Hepatocellular carcinoma
Core Tip The study revealed that the expression of SAC3 domain containing 1 (SAC3D1) was elevated in hepatocellular carcinoma and closely related to a poor prognosis. SAC3D1 facilitated the proliferation and migration of hepatocellular carcinoma cells in vitro and in vivo. The increase of SAC3D1 Leads to more β-Catenin accumulating in the nucleus, facilitating the expression of c-Myc, one of the upstream regulatory factors of glycolysis. The iCRT3, an antagonist of β-Catenin, could counteract the increase of c-Myc induced by SAC3D1, while also downregulating the expression of glycolysis-related proteins. In conclusion, SAC3D1 augmented glycolysis and adenosine triphosphate generation via β-Catenin/c-Myc axis.
Citation Lin XJ, Tang JE, Sun B, Wang AL, Chen Y, Chen L, Xue YY, Li AJ, Liu CY. SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press
Received
2025-04-11 08:17
Peer-Review Started
2025-04-11 08:17
To Make the First Decision
Return for Revision
2025-04-25 11:19
Revised
2025-05-08 08:54
Second Decision
2025-06-19 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2025-06-19 06:20
Articles in Press
2025-06-19 06:20
Publication Fee Transferred
2025-05-09 06:26
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com